Entering text into the input field will update the search result below

UBS upgrades Alnylam to buy; sees 5-year revenue CAGR surpassing 40%

Oct. 04, 2021 12:30 PM ETAlnylam Pharmaceuticals, Inc. (ALNY) StockBy: Jonathan Block, SA News Editor

Woman looking stock market Data on smart phone

Orientfootage/iStock via Getty Images

  • UBS has upgraded shares of Alnylam Pharmaceuticals (ALNY +1.8%) from hold to buy and boosted its price target to $215 (~12% upside).
  • Analyst Esther Rajavelu says that over the next year to two years, "we expect

Recommended For You

More Trending News

About ALNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ALNY--
Alnylam Pharmaceuticals, Inc.